⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib)

Name: KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib) - AI Visibility Score
Creator: Engagemii
Published: 2026-06-28T05:29:04.238Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

keytrudalenvima.com

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib) just got measured.

5/10 means KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib) is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib)

Learn about how KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib) are used as a combination treatment for certain types of cancer.

Key Topics

An FDA-approved combination treatment to help fight certain types of cancer KEYTRUDA + LENVIMA

Details

Industry: Healthcare

keytrudalenvima.com

AI Visibility Breakdown

Structured Data

Content Structure

Entity Clarity

E-E-A-T Signals

Technical AEO

AI Discoverability

Is this your brand?

Claim free. You'll see:

✓

Your full 6-category score breakdown

✓

Exact fixes: robots.txt, schema, llms.txt

✓

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

✓

Personal 50% off code at checkout

Password (8+ characters)

Already have an account? Sign in

Picked for KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib): Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib).

Source & Attribution

Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/keytrudalenvima

Cite this score: Engagemii (2026). "AEO Score for KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib)." Retrieved from https://engagemii.com/aeo/brands/keytrudalenvima

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.